Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Carmell Therapeutics Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | N/A | -$0.14 | N/A | N/A | $20,519 |
| 08/14/2024 | Q2 2024 | N/A | -$0.16 | N/A | N/A | $12,320 |
| 03/29/2024 | Q1 2024 | N/A | -$0.21 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | $0.29 | N/A | N/A | $-3,728,816 |
| 09/29/2023 | Q3 2023 | N/A | -$0.62 | N/A | N/A | $3.73 M |
| 06/29/2023 | Q2 2023 | N/A | $0.02 | N/A | N/A | $0 |
| 03/29/2023 | Q1 2023 | N/A | $0.03 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.16 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.32 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$0.02 | N/A | N/A | $0 |
| 05/20/2022 | Q1 2022 | N/A | -$0.03 | N/A | N/A | $0 |
| 04/15/2022 | Q4 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 11/22/2021 | Q3 2021 | N/A | -$0.00 | N/A | N/A | $0 |
| 09/13/2021 | Q2 2021 | N/A | -$3,295.79 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Carmell Therapeutics Corporation Earnings: FAQ's
Carmell Therapeutics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 7th, 2025 based offlast year's report dates.
The conference call for Carmell Therapeutics Corporation's latest earnings report can be listened to online.
The conference call transcript for Carmell Therapeutics Corporation's latest earnings report can be read online.
Carmell Therapeutics Corporation (:CTCX) has a recorded net income of $-15,445,087.Carmell Therapeutics Corporation has generated $-1.46 earnings per share over the last four quarters.
Carmell Therapeutics Corporation (:CTCX) has a price-to-earnings ratio of -0.21 and price/earnings-to-growth ratio is 0.